Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • News
    • Diabetes and Endo
    • Its alarming- 463...

    Its alarming- 463 million Diabetes patients globally and numbers continue to rise

    Written by Dr. Kamal Kant Kohli Kohli Published On 2019-11-15T20:20:08+05:30  |  Updated On 15 Nov 2019 8:20 PM IST
    Its alarming- 463 million Diabetes patients globally and numbers continue to rise

    On World Diabetes Day, the International Diabetes Federation (IDF) has released new figures that highlight the alarming growth in the prevalence of diabetes around the world. In all 38 million more adults are now estimated to be living with diabetes compared to the results published in 2017 and the current figure shows that there are now 463 million adults with diabetes worldwide. The new findings have been published in the 9th Edition of the International Diabetes Federation Diabetes Atlas.




    The latest Atlas reports that the global prevalence of diabetes has reached 9.3%, with more than half (50.1%) of adults undiagnosed. Type 2 diabetes accounts for around 90% of all people with diabetes.





    The rise in the number of people with type 2 diabetes is driven by a complex interplay of socio-economic, demographic, environmental and genetic factors. Key contributors include urbanisation, an ageing population, decreasing levels of physical activity and increased levels of overweight and obesity. For reasons which are unknown, type 1 diabetes is also on the rise.


    "Diabetes is a serious global health issue that has a huge socio-economic impact that cannot be ignored," said IDF President, Professor Nam H. Cho. "The rising prevalence of diabetes is a real cause for concern, especially when we consider the high number of people who remain undiagnosed. We must do more to prevent type 2 diabetes, diagnose all forms of diabetes early and prevent complications. We must also ensure that every person with diabetes has affordable and uninterrupted access to the care they need."


    Diabetes has an impact on all age groups, regardless of geography and income. More than 1.1 million children and adolescents younger than 20 years are living with type 1 diabetes, while three in every four people with diabetes (352 million) are of working age (20-64 years). One in five people over 65 has diabetes. The rise in prevalence is putting a strain on the capacity of countries to guarantee regular and affordable access to essential medicines and appropriate care. This leaves many struggling to manage their diabetes, placing their health at serious risk.


    When their diabetes is undetected or they are inadequately supported, people with diabetes are at risk of serious and life-threatening complications, such as heart attack, stroke, kidney failure, blindness and lower-limb amputation. These result in reduced quality of life and higher healthcare costs and place undue stress on families.


    "The IDF Diabetes Atlas provides information for those who have to make decisions about diabetes care and prevention and for those who seek to influence such decisions," said IDF Diabetes Atlas Committee Chair, Professor Rhys Williams. "A considerable amount of research and new evidence has been collated for the 9th edition. We have seen an improvement in the number of in-country studies that support our estimates and projections, as we endeavour to inform the diabetes community and the wider public about the condition's prevalence around the world".


    Much can be done to reduce the impact of diabetes. Evidence suggests that type 2 diabetes can often be prevented, while early diagnosis and access to appropriate care for all types of diabetes can avoid or delay complications in people living with the condition.


    Other key findings from the IDF Diabetes Atlas 9th Edition include:




    • The total number of people with diabetes is predicted to rise to 578 million by 2030 and to 700 million by 2045.

    • 374 million adults have impaired glucose tolerance, placing them at high risk of developing type 2 diabetes.

    • Diabetes was responsible for an estimated USD 760 billion in health expenditure in 2019.

    • Diabetes is among the top 10 causes of death, with almost half of deaths occurring in people under the age of 60 years.

    • One in six live birth is affected by hyperglycaemia in pregnancy.


    For more information and supporting data about the national, regional and global prevalence of diabetes included in the IDF Diabetes Atlas 9th Edition, visit https://www.diabetesatlas.org?utm_source=media&utm_medium=email&utm_campaign=world_diabetes_day_2019_press_release



    diabetesDiabetes AtlasInternational Diabetes FederationWorld Diabetes Day

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Dr. Kamal Kant Kohli Kohli
    Dr. Kamal Kant Kohli Kohli
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok